The Journal of Organic Chemistry
Article
1
NMR (50 MHz, CDCl3) δ 154.8, 154.1, 139.2, 122.0, 115.1, 108.3,
86.1, 71.0, 66.0, 39.3, 35.3, 29.9, 26.1, 25.9, 20.8, 18.5, 18.4, 16.3, 1.24,
−3.7, −4.1; HRMS (CI MS) m/z for C26H47O3Si2 (M + H)+ calcd
463.3058, found 463.3062; TLC Rf 0.64 (10% EtOAc/petroleum
ether) (UV, I2).
Alboatrin (4). Alboatrin (4) was prepared from 24 (600 mg, 1.3
mmol) in 92% yield following the procedure described for the
preparation of 13: mp 148−149 °C (lit.6f mp 148−149 °C); 1H NMR
(400 MHz, CDCl3) δ 6.29 (d, 1H, J = 2.0 Hz), 6.21(d, 1H, J = 2.4
Hz), 4.66 (brs, 1H), 4.18 (t, 1H, J = 8.2 Hz), 3.51 (t, 1H, J = 8.6 Hz),
2.70−2.68 (m, 2H), 2.19 (s, 3H), 2.15−2.09 (m, 1H), 1.93 (ddd, 1H, J
= 11.0 Hz, J = 5.5 Hz, J = 2.0 Hz), 1.50 (s, 3H), 1.06 (d, 3H, J = 6.4
Hz); 13C NMR (100 MHz, CDCl3) δ 154.7, 153.9, 138.4, 109.7, 109.6,
107.2, 101.7, 74.1, 48.2, 35.4, 22.9, 21.6, 19.5, 16.0; HRMS (CI MS)
m/z for C14H19O3 (M + H)+ calcd 235.1329, found 235.1333; TLC Rf
0.14 (10% EtOAc/petroleum ether) (UV, I2).
for the preparation of 13: mp 122−123 °C; H NMR (200 MHz,
CDCl3) δ 6.96 (t, 1H, J = 8.1 Hz), 6.44 (d, 1H, J = 8.0 Hz), 6.37 (d,
1H, J = 7.8 Hz), 5.53 (brs, 1H), 4.21 (t, 1H, J = 8.3 Hz), 3.54 (t, 1H, J
= 8.4 Hz), 2.90 (dd, 1H, J = 24.3 Hz, J = 1.4 Hz), 2.74 (dd, 1H, J =
17.5 Hz, J = 6.2 Hz), 2.24−2.06 (m, 1H), 2.00−1.90 (m, 1H), 1.53 (s,
3H), 1.07 (d, 3H, J = 6.6 Hz); 13C NMR (50 MHz, CDCl3) δ 154.6,
154.3, 127.7, 109.8, 107.4, 107.0, 106.4, 74.2, 47.7, 35.6, 23.0, 19.0,
16.1; HRMS (CI MS) m/z for C13H17O3 (M + H)+ calcd 221.1172,
found 221.1178; TLC Rf 0.44 (20% EtOAc/petroleum ether) (UV, I2).
Xyloketal D (2). To a solution containing 35 (220 mg, 1 mmol) in
7 mL of 1,2-dichloroethane at −10 °C was added 4 mL (4 mmol) of
TiCl4 (1.0 M in CH2Cl2). The reaction mixture was stirred for 5 min
at −10 °C, and 1.2 mL (120 mg, 1.5 mmol) of acetyl chloride solution
in DCE (from stock solution: 1.1 mL acetyl chloride dissolved in 10
mL DCE) was added. The reaction mixture was stirred at room
temperature for 24 h. Then the reaction mixture was poured into 50
mL of 2 N HCl (aq), filtered through a pad of Celite, and washed with
30 mL of ethyl acetate. The organic phase was separated, and the
aqueous phase was extracted with (3 × 10 mL) ethyl acetate. The
combined organic phase was dried (Na2SO4) and concentrated under
reduced pressure to afford a crude residue. The residue was purified by
flash chromatography on a silica gel column. Elution with 1:5 ethyl
acetate−hexanes gave 2 as a white solid: yield 214 mg (82%): mp 78−
3-[(2,6-Dimethoxyphenyl)hydroxymethyl]-4-methyldihy-
drofuran-2-one (27). Aldol product 27 was prepared from aldehyde
25 (1.66 g, 10 mmol) and lactone 20 (1.5 g, 15 mmol) in 90% yield
following the procedure described for the preparation of 16: mp 62−
1
63 °C; H NMR (200 MHz, CDCl3) δ 7.16 (t, 2H, J = 8.4 Hz), 6.49
(d, 4H, J = 8.4 Hz), 5.57−5.49 (m, 1H), 5.32(t, 1H, J = 7.9 Hz), 4.34−
4.22 (m, 2H), 3.76 (s, 12 H), 3.71−3.58 (m, 2H), 2.86(t, 1H, J = 8.3
Hz), 2.81−2.70 (m, 1H), 2.51(dd, 1H, J = 7.6 Hz, J = 5.4 Hz), 2.27−
2.13(m, 1H), 0.86 (d, 3H, J = 6.6 Hz), 0.68 (d, 3H, J = 6.6 Hz); 13C
NMR (50 MHz, CDCl3) δ 178.9, 177.0, 158.3, 157.6, 129.5, 129.1,
116.0, 116.0, 104.4, 104.3, 72.9, 72.7, 67.0, 66.4, 55.8, 55.7, 53.2, 51.3,
33.5, 31.6, 18.2, 17.0; HRMS (ESI-TOF) m/z for C14H18NaO5 (M +
Na)+ calcd 289.1046, found 289.1046; TLC Rf 0.48 (30% EtOAc/
petroleum ether) (UV, I2).
3-(2, 6-Dimethoxybenzyl)-4-methyldihydrofuran-2-one (29).
Reduction product 29 was prepared from 27 (2.4g, 9 mmol) in 98%
yield following the procedure described for the preparation of 17: mp
71−72 °C, IR (neat) 1771 cm−1; 1H NMR (200 MHz, CDCl3) δ 7.16
(t, 1H, J = 8.3 Hz), 6.53 (d, 2H, J = 8.4 Hz), 4.31 (dd, 1H, J = 8.7 Hz, J
= 7.6 Hz), 3.80 (s, 6H), 3.63 (t, 1H, J = 8.5 Hz), 3.17 (dd, 1H, J = 13.2
Hz, J = 5.0 Hz), 2.92 (dd, 1H, J = 13.2 Hz, J = 10 Hz), 2.59−2.43 (m,
1H), 2.40−2.27 (m, 1H), 0.71 (d, 3H, J = 6.4 Hz); 13C NMR (50
MHz, CDCl3) δ 179.8, 158.6, 127.8, 115.0, 103.7, 72.8, 55.7, 45.8,
36.3, 23.3, 17.2; HRMS (CI MS) m/z for C14H19O4 (M + H)+ calcd
251.1278, found 251.1281; TLC Rf 0.72 (20% EtOAc/petroleum
ether), (UV, I2).
79 °C (lit.6b mp 82 °C); H NMR (400 MHz, CDCl3) δ 13.12 (s,
1
1H), 7.52 (d, 1H, J = 9.2 Hz), 6.37 (d, 1H, J = 8.8 Hz), 4.21 (t, 1H, J =
8.4 Hz), 3.57 (t, 1H, J = 8.6 Hz), 2.96 (d, 1H, J = 18.0 Hz), 2.72 (dd,
1H, J = 17.8 Hz, J = 6.0 Hz), 2.55 (s, 3H), 2.10−1.96 (m, 2H), 1.53 (s,
3H), 1.08 (d, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3) δ 203.0,
163.1, 159.7, 130.2, 113.3, 109.0, 108.5, 106.3, 74.5, 47.1, 35.3, 26.4,
22.9, 18.2, 16.0; HRMS (ESI-TOF) m/z for C15H18NaO4 (M + Na)+
calcd 285.1097, found 285.1102; TLC Rf 0.28 (20% EtOAc/petroleum
ether) (UV, I2).
3-[(2,4-Dimethoxyphenyl)hydroxymethyl]-4-methyldihy-
drofuran-2-one (28). Aldol product 28 was prepared from aldehyde
26 (1.66 g, 10 mmol) and lactone 20 (1.5 g, 15 mmol) in 93% yield
following the procedure described for the preparation of 16: 1H NMR
(200 MHz, CDCl3) δ 7.39 (t, 2H, J = 8.1 Hz), 6.54−6.45 (m, 4H),
5.53 (brs, 1H), 5.16 (d, 1H, J = 8.2 Hz), 4.35 (t, 2H, J = 7.9 Hz), 3.81
(s, 12H), 3.68 (dt, 2H, J = 8.8 Hz, J = 3.4 Hz), 2.82−2.50 (m, 4H),
0.67 (d, 3H, J = 6.4 Hz), 0.65 (d, 3H, J = 6.2 Hz); 13C NMR (50 MHz,
CDCl3) δ 179.1, 178.5, 160.1, 159.8, 157.0, 156.1, 128.3, 126.6, 121.9,
121.1, 104.2, 103.6, 97.7, 97.6, 72.9, 72.8, 67.6, 65.7, 54.9, 54.9, 52.4,
51.6, 33.0, 29.2, 20.5, 17.4, 16.2, 13.8; HRMS (ESI-TOF) m/z for
C14H18NaO5 (M + Na)+ calcd 289.1046, found 289.1044; TLC Rf 0.22
(20% EtOAc/petroleum ether), (UV, I2).
3-[2,6-Bis(tert-butyldimethylsilanyloxy)benzyl]-4-methyldi-
hydrofuran-2-one (31). Compound 31 was prepared from 29 (2.0g,
8 mmol) in 76% yield following the procedure described for the
1
3-(2,4-Dimethoxybenzyl)-4-methyldihydrofuran-2-one (30).
Reduction product 30 was prepared from 28 (2.4 g, 9 mmol) in 96%
yield following the procedure described for the preparation of 17: mp
preparation of 18: mp 111−112 °C; H NMR (200 MHz, CDCl3) δ
6.95 (t, 1H, J = 8.2 Hz), 6.46 (d, 2H, J = 8.2 Hz), 4.32 (t, 1H, J = 8.1
Hz), 3.62 (t, 1H, J = 8.7 Hz), 3.17 (dd, 1H, J = 13.2 Hz, J = 4.0 Hz),
2.88 (dd, 1H, J = 11.9 Hz, J = 10.6 Hz), 2.58 (ddd, 1H, J = 10.1 Hz, J =
9.7 Hz, J = 4.2 Hz), 2.50−2.39 (m, 1H), 1.01 (s, 18H), 0.68 (d, 3H, J
= 6.2 Hz), 0.26 (s, 6H), 0.24 (s, 6H); 13C NMR (50 MHz, CDCl3) δ
179.4, 155.3, 127.0, 120.4, 111.8, 72.7, 45.7, 36.8, 26.1, 25.9, 25.1, 18.5,
17.1, −3.9; HRMS (CI MS) m/z for C24H43O4Si2 (M + H)+ calcd
451.2694, found 451.2697; TLC Rf 0.44 (5% EtOAc/petroleum ether)
(UV, I2).
1
92−93 °C; H NMR (200 MHz, CDCl3) δ 7.05 (d, 1H, J = 7.8 Hz),
6.39(s, 1H), 6.37 (d, 1H, J = 7.6 Hz), 4.21(t, 1H, J = 8.2 Hz), 3.75 (s,
3H), 3.73 (s, 3H), 3.59 (t, 1H, J = 9.0 Hz), 3.15 (dd, 1H, J = 13.7 Hz, J
= 5.2 Hz), 2.82−2.60 (m, 1H), 2.49−2.38 (m, 1H), 2.28−2.12 (m,
1H), 0.82 (dd, 3H, J = 6.4 Hz, J = 0.8 Hz); 13C NMR (50 MHz,
CDCl3) δ 179.3, 159.8, 158.4, 131.3, 118.8, 104.0, 98.2, 72.5, 55.2,
55.1, 46.8, 35.7, 29.0, 16.5; HRMS (ESI-TOF) m/z for C14H18NaO4
(M + Na)+ calcd 273.1097, found 273.1096; TLC Rf 0.44 (20%
EtOAc/petroleum ether) (UV, I2).
3-[2,6-Bis(tert-butyldimethylsilanyloxy)benzyl]-2-methyl-
pent-4-yn-1-ol (33). Compound 33 (colorless liquid) was prepared
from 31 (1.35 g, 3 mmol) in 70% yield following the procedure
3-[2,4-Bis(tert-butyldimethylsilanyloxy)benzyl]-4-methyldi-
hydrofuran-2-one (32). Compound 32 was prepared from 30 (2.0 g,
8 mmol) in 79% yield following the procedure described for the
preparation of 18: mp 70−72 °C; 1H NMR (200 MHz, CDCl3) δ 6.96
(d, 1H, J = 8.2 Hz), 6.38 (dd, 1H, J = 7.8 Hz, J = 2.4 Hz), 6.31 (d, 1H,
J = 2.4 Hz), 4.23 (t, 1H, J = 8.3 Hz), 3.61 (t, 1H, J = 9.0 Hz), 3.34−
3.21 (m, 1H), 2.60−2.41 (m, 2H), 2.35−2.23 (m, 1H), 0.98 (s, 9H),
0.94 (s, 9H), 0.71 (d, 3H, J = 6.6 Hz), 0.22 (s, 6H), 0.15 (s, 6H); 13C
NMR (50 MHz, CDCl3) δ 179.3, 155.2, 154.5, 131.2, 121.9, 113.3,
111.0, 72.7, 46.8, 36.2, 30.5, 25.9, 25.8, 18.3, 18.1, 17.0, −3.5, −3.9,
−4.1, −4.3; HRMS (ESI-TOF) m/z for C24H42NaO4Si2 (M + Na)+
calcd 473.2514, found 473.2514; TLC Rf 0.48 (10% EtOAc/petroleum
ether), (UV, I2).
1
described for the preparation of 24: H NMR (200 MHz, CDCl3) δ
6.95−6.87 (m, 1H), 6.44−6.38 (m, 2H), 3.94−3.86 (m, 1H), 3.53−
3.41 (m, 1H), 3.09−2.88 (m, 2H), 2.67−2.59 (m, 1H), 1.80 (d, 1H, J
= 2.4 Hz), 1.80−1.62 (m, 1H), 1.07 (d, 3H, J = 6.8 Hz), 1.01 (s, 18H),
0.24 (s, 6H), 0.23 (s, 6H); 13C NMR (50 MHz, CDCl3) δ 155.4,
126.6, 121.6, 111.4, 85.5, 70.2, 65.3, 39.5, 34.4, 27.6, 26.2, 18.5, 16.3,
1.25, 0.39, −0.25, −3.8, −3.9; HRMS (ESI-TOF) m/z for
C25H44NaO3Si2 (M + Na)+ calcd 471.2721, found 471.2722; TLC Rf
0.82 (10% EtOAc/petroleum ether) (UV, I2).
3,9a-Dimethyl-2,3,3a,9a-tetrahydro-4H-1,9-dioxacyclo-
penta[b]naphthalen-5-ol (35). Compound 35 was prepared from
33 (896 mg, 2 mmol) in 94% yield following the procedure described
2419
dx.doi.org/10.1021/jo302545n | J. Org. Chem. 2013, 78, 2413−2421